All questionsSpecific populations: Verzenio (abemaciclib), all indications7 questions · 1 sourcePregnancy and breastfeedingCan Verzenio be used during pregnancy?“Based on findings from animal studies and the mechanism of action, VERZENIO can cause fetal harm when administered to a pregnant woman. In animal reproduction studies, administration of abemaciclib to pregnant rats during the period of organogenesis caused teratogenicity and decreased fetal weight at maternal exposures that were similar to the human clinical exposure based on area under the curve (AUC) at the maximum recommended human dose.” (opens the source at this quote in a new tab)CopyFlag“Advise pregnant women of the potential risk to a fetus. Advise females of reproductive potential to use effective contraception during treatment with VERZENIO and for 3 weeks after the last dose [see Use in Specific Populations (8.1, 8.3) and Clinical Pharmacology (12.1)].” (opens the source at this quote in a new tab)CopyFlag“Refer to the Prescribing Information of the agents administered in combination with VERZENIO for pregnancy information.” (opens the source at this quote in a new tab)CopyFlagHow long should birth control be used after stopping Verzenio?“Advise females of reproductive potential to use effective contraception during VERZENIO treatment and for 3 weeks after the last dose.” (opens the source at this quote in a new tab)CopyFlag“Refer to the Prescribing Information of the agents administered in combination with VERZENIO for contraception and infertility information. When used in combination, advise patients to use effective contraception during treatment and for the longest post-treatment duration recommended in the prescribing information of the individual products.” (opens the source at this quote in a new tab)CopyFlagCan Verzenio be used while breastfeeding?“There are no data on the presence of abemaciclib in human milk, or its effects on the breastfed child or on milk production. Because of the potential for serious adverse reactions in breastfed infants from VERZENIO, advise lactating women not to breastfeed during VERZENIO treatment and for 3 weeks after the last dose.” (opens the source at this quote in a new tab)CopyFlag“Refer to the Prescribing Information of the agents administered in combination with VERZENIO for lactation information. When used in combination, advise patients to not breastfeed during treatment and for the longest post-treatment duration recommended in the prescribing information of any of the individual products.” (opens the source at this quote in a new tab)CopyFlagSpecific populationsDoes Verzenio affect male fertility?“Based on findings in animals, VERZENIO may impair fertility in males of reproductive potential [see Nonclinical Toxicology (13.1)].” (opens the source at this quote in a new tab)CopyFlag“Abemaciclib may impair fertility in males of reproductive potential. In repeat-dose toxicity studies up to 3-months duration, abemaciclib-related findings in the testis, epididymis, prostate, and seminal vesicle at doses ≥10 mg/kg/day in rats and ≥0.3 mg/kg/day in dogs included decreased organ weights, intratubular cellular debris, hypospermia, tubular dilatation, atrophy, and degeneration/necrosis. These doses in rats and dogs resulted in approximately 2 and 0.02 times, respectively, the exposure (AUC) in humans at the maximum recommended human dose. In a rat male fertility study, abemaciclib had no effects on mating and fertility at oral doses up to 10 mg/kg/day (approximately 2 times the exposure at the maximum recommended human dose based on AUC).” (opens the source at this quote in a new tab)CopyFlagDoes Verzenio need a dose adjustment for kidney impairment?“No dosage adjustment is required for patients with mild or moderate renal impairment (CLcr ≥30-89 mL/min, estimated by Cockcroft-Gault [C-G]). The pharmacokinetics of abemaciclib in patients with severe renal impairment (CLcr <30 mL/min, C-G), end stage renal disease, or in patients on dialysis is unknown [see Clinical Pharmacology (12.3)].” (opens the source at this quote in a new tab)CopyFlagDoes Verzenio need a dose adjustment for liver impairment?“For patients with severe hepatic impairment (Child Pugh-C), reduce the VERZENIO dosage frequency to once daily [see Use in Specific Populations (8.7) and Clinical Pharmacology (12.3)].” (opens the source at this quote in a new tab)CopyFlag“No dosage adjustments are necessary in patients with mild or moderate hepatic impairment (Child-Pugh A or B).” (opens the source at this quote in a new tab)CopyFlag“In subjects with severe hepatic impairment, the mean plasma elimination half-life of abemaciclib increased to 55 hours compared to 24 hours in subjects with normal hepatic function.” (opens the source at this quote in a new tab)CopyFlagPediatric useIs Verzenio approved for children?“The safety and effectiveness of VERZENIO have not been established in pediatric patients.” (opens the source at this quote in a new tab)CopyFlag